Correlation Between Checkpoint Therapeutics and Palatin Technologies
Can any of the company-specific risk be diversified away by investing in both Checkpoint Therapeutics and Palatin Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Checkpoint Therapeutics and Palatin Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Checkpoint Therapeutics and Palatin Technologies, you can compare the effects of market volatilities on Checkpoint Therapeutics and Palatin Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Checkpoint Therapeutics with a short position of Palatin Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Checkpoint Therapeutics and Palatin Technologies.
Diversification Opportunities for Checkpoint Therapeutics and Palatin Technologies
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Checkpoint and Palatin is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and Palatin Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Palatin Technologies and Checkpoint Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Checkpoint Therapeutics are associated (or correlated) with Palatin Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Palatin Technologies has no effect on the direction of Checkpoint Therapeutics i.e., Checkpoint Therapeutics and Palatin Technologies go up and down completely randomly.
Pair Corralation between Checkpoint Therapeutics and Palatin Technologies
Given the investment horizon of 90 days Checkpoint Therapeutics is expected to generate 0.76 times more return on investment than Palatin Technologies. However, Checkpoint Therapeutics is 1.32 times less risky than Palatin Technologies. It trades about -0.05 of its potential returns per unit of risk. Palatin Technologies is currently generating about -0.04 per unit of risk. If you would invest 349.00 in Checkpoint Therapeutics on November 2, 2024 and sell it today you would lose (65.00) from holding Checkpoint Therapeutics or give up 18.62% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 98.33% |
| Values | Daily Returns |
Checkpoint Therapeutics vs. Palatin Technologies
Performance |
| Timeline |
| Checkpoint Therapeutics |
| Palatin Technologies |
Checkpoint Therapeutics and Palatin Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Checkpoint Therapeutics and Palatin Technologies
The main advantage of trading using opposite Checkpoint Therapeutics and Palatin Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Checkpoint Therapeutics position performs unexpectedly, Palatin Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Palatin Technologies will offset losses from the drop in Palatin Technologies' long position.| Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
| Palatin Technologies vs. Fortress Biotech | Palatin Technologies vs. Checkpoint Therapeutics | Palatin Technologies vs. Avenue Therapeutics | Palatin Technologies vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |